1Screaton GR;Bell MV;Jacson DG.Genomic structure of DNA encoding the lyphooyte homing recepor CD44 reveals at least 12 alternatively spliced exons,1992(24).
2Ghigna C;Moroni M;Porta C.Altered expression of heterogencous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas,1998(24).
3Bell MV;Cowper AE;Lefranc MP.Influence of intron length on alternative splicing of CD44[J],1998(10).
4Reeder JA;Gotley DC;Walsh MD.Expression of antisense CD44variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment,1998(16).
5Arurfo A;Stamenkovic I;Melinck M.CD44 is the principal cell surface receptor for hyaluronate[J],1990(07).
6Yu Q;Stamenkovic I.Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion,1999(01).
7Katoh S;Zheng Z;Oritani K.Glycosylation of CD44 negatively regulates its recognition of hyaluronan[J],1995(02).
8Maiti A;Maki G;Johnson P.TNF-α induction of CD44-mediated leukocyte adhesion by sulfation[J],1998(5390).
9Gunthert U;Hofmann M;Rudy W.A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells[J],1991(01).
10Lackner C;Moser R;Bauernhofer T.Soluble CD44 v5 and v6 in serum of pationts with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis[J],1998(01).
3Chun S Y, Bae O S, Kim J B, etal. The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes[ J ]. J Korean Med Sci,2O00,15(6) :696-700.
4Nanashima A, Yamaguchi H, Sawai T, et al. Expression of adhesi Gemolecules in hepatic metastases of colorectal carcinoma: relationship to primary tumors and prognosis after hepatic resection [J ]. J Gastroenterol Hepatol, 1999,14(10) : 1004-1009.
5Yamane N, Tsujitani S, Makino M, et al. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer[J]. Oncology,1999,56 (3): 232-238.
6Matzku S, Wenzel A, Liu S, etal. Antigenic differences between metastaticand nonmetastatie BSp73 rat tumor variants chatacterized by monoclonal antibodies[J]. Cancer Res, 1989,49(5) : 1294-1299.
7Gunthert U, Hofinann M, Rudy W, et al. A new vatiemt of glycoprotein CD44 coders metastatic potential to rat carcinoma cells[J]. Cell, 1991,65(1):13-24.
8Wiggers T, Arends J W, Versfijnen C, et al. Prognostic significance of CEA inmunoreactivity patterns in large bowel carcinoma tissue[J]. Br J Cancer, 1986,54(3) :409-414.
10Kazuhisa T, Fumiyuki T, Michihiro H, et al . Restoration of CD44+ s in non-small cell lung cancer cells enhanced their susceptibility to the macrophage-cyt-otoxicity [ J ]. Lung cancer, 2003, 41 (2) : 145 - 153.
